tigit nb2 79794 (Novus Biologicals)
93
Structured Review
Novus Biologicals
tigit nb2 79794
Tigit Nb2 79794, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tigit+nb2+79794/TIGIT+Antibody+(TIGIT%2F3106)/pm41382272-1067-50-52
Average 93 stars, based on 2 article reviews
Tigit Nb2 79794, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tigit+nb2+79794/TIGIT+Antibody+(TIGIT%2F3106)/pm41382272-1067-50-52
Average 93 stars, based on 2 article reviews
tigit nb2 79794 - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Western Blot:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Flow Cytometry:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) In Vivo:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Control:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) |